| Spontaneous abortion occurred in 4 patients who participated in
Betaseron ® trials, however it is not known whether Betaseron
was related to these events. Pregnant women
should be advised that there may be a risk of potential hazard to the
fetus should interferon therapy be continued.
Discontinuation of therapy is advised.
|